# J&A Vendor Managed Inventory Neulasta Product

Canonical: https://abierto.us/opportunities/75a50124c00011

- Solicitation number: BARDA75A50124C00011
- Notice type: Justification (first published as award notice)
- Status: Awarded to Amgen USA Inc. for $580,406.73
- Department: Department of Health and Human Services
- Agency: Office of Assistant Secretary for Preparedness and Response
- Contracting office: Aspr Barda Div Contracts MGMT & Acq (75ANBA)
- Product or service code: AN13 Health R&D Services; Health Care Services; Experimental Development
- Place of performance: Thousand Oaks, California
- County: Ventura County (FIPS 06111). https://abierto.us/counties/ventura-county-ca-06111
- City: Thousand Oaks. https://abierto.us/cities/thousand-oaks-ca-0678582
- First posted: March 11, 2024
- Last posted: March 12, 2024
- SAM.gov: https://sam.gov/workspace/contract/opp/2da09eaedfff4c7198b3f526e90998b8/view

## Description

This is a Justification & Approval (J&A) in accordance with FAR 6.302-1 Only one responsible source and no other supplies or services will satisfy agency requirements. A full and open competition for a single award IDIQ contract HHSO100201300006I was awarded in September 2013 under solicitation RFP12100SOL00016 to Amgen USA Inc. Task orders HHSO10033003T and HHSO10033004T were awarded in August and September 2018 for the procurement of 165,906 doses of Neulasta product and Vendor Managed Inventory (VMI).

This is a six-month bridge contract requirement to maintain VMI services until the Strategic National Stockpile (SNS) can competitively solicit, evaluate, and award a contract. FAR Clause 52.217-8 has been negotiated with Amgen USA Inc. and if exercised shall not exceed three-months. If no action is taken to maintain the current inventory levels in VMI beyond March 12, 2024, $395M worth of assets being held for the USG will be transferred to an SNS warehouse and begin to expire without Vendor stock rotation. Keeping the product in place while SNS completes its acquisition process preserves the ability of the United States Government (USG) to keep the product from expiring.

## Award on USAspending

- Recipient: Amgen USA Inc. (UEI XPGNQMXHP493)
- Contract: 75A50124C00011, definitive contract
- Obligated: $811,924.33
- Competition: Not Competed, 1 offers received
- Link: award number 75A50124C00011 equals the contract number; same sub-agency 7505 (high confidence)
- Record: https://www.usaspending.gov/award/CONT_AWD_75A50124C00011_7505_-NONE-_-NONE-/


## Publications

- March 11, 2024: Award notice. Notice 99f4729e79ab4fd697c59245d53b3fc6. https://sam.gov/workspace/contract/opp/99f4729e79ab4fd697c59245d53b3fc6/view
- March 12, 2024: Justification. Notice 2da09eaedfff4c7198b3f526e90998b8. https://sam.gov/workspace/contract/opp/2da09eaedfff4c7198b3f526e90998b8/view

## Points of contact

- richard Hall, richard.hall@hhs.gov

---
Source: SAM.gov Contract Opportunities bulk extract and USAspending.gov award data. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/75a50124c00011.